Melody Cobleigh to Spiro Compounds
This is a "connection" page, showing publications Melody Cobleigh has written about Spiro Compounds.
Connection Strength
0.021
-
Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council Study. Invest New Drugs. 1989 Jul; 7(2-3):223-4.
Score: 0.021
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.